Paper8740979
Circulating immune markers in advanced renal cell carcinoma during immunotherapy with interferon gamma.
Höbarth K and 5 others. Urol Res, 1996. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Circulating immune markers in advanced renal cell carcinoma during immunotherapy with interferon gamma. Papers, record 8740979. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8740979
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Circulating immune markers in advanced renal cell carcinoma during immunotherapy with interferon gamma.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers | Major topic |
| Carcinoma, Renal Cell | Major topic |
| Immunotherapy | Major topic |
| Interferon-gamma | Major topic |
| Kidney Neoplasms | Major topic |
| Adult | |
| Aged | |
| CD4 Antigens | |
| CD8 Antigens | |
| E-Selectin | |
| Female | |
| Histocompatibility Antigens Class I | |
| Humans | |
| Intercellular Adhesion Molecule-1 | |
| Male | |
| Middle Aged | |
| beta 2-Microglobulin |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3289570 | Role of the major histocompatibility complex class I antigens in tumor growth and metastasis. | Annu Rev Immunol | 1988 | https://conductscience.org/library/papers/3289570 | PubMed |
| 2 | 3873616 | Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection. | Nature | 1985 | https://conductscience.org/library/papers/3873616 | PubMed |
| 3 | 6425403 | Modulation of class I HLA antigens on HL-60 promyelocytic leukemia cells by serum-free medium: re-induction by gamma-IFN and 1,25-dihydroxyvitamin D3 (calcitriol). | J Immunol | 1984 | https://conductscience.org/library/papers/6425403 | PubMed |
| 4 | 6206183 | Activation of human macrophages. Comparison of other cytokines with interferon-gamma. | J Exp Med | 1984 | https://conductscience.org/library/papers/6206183 | PubMed |
| 5 | 301122 | Depressed in vitro peripheral blood lymphocyte response to mitogens in cancer patients: the role of suppressor cells. | Int J Cancer | 1977 | https://conductscience.org/library/papers/301122 | PubMed |
| 6 | 3129362 | Interferon-gamma for the treatment of metastatic renal cancer: dose-dependent stimulation and downregulation of beta-2 microglobulin and neopterin responses. | Immunobiology | 1987 | https://conductscience.org/library/papers/3129362 | PubMed |
| 7 | 2408137 | Expression of activation antigens on T cells in rheumatoid arthritis patients. | Scand J Immunol | 1990 | https://conductscience.org/library/papers/2408137 | PubMed |
| 8 | 2421465 | The regulation of expression of major histocompatibility complex products. | Transplantation | 1986 | https://conductscience.org/library/papers/2421465 | PubMed |
| 9 | 4044058 | Lung colonization and metastasis by disseminated B16 melanoma cells: H-2 associated control at the level of the host and the tumor cell. | Int J Cancer | 1985 | https://conductscience.org/library/papers/4044058 | PubMed |
| 10 | 1691492 | Immunophenotypic markers in renal cell carcinoma. | Mod Pathol | 1990 | https://conductscience.org/library/papers/1691492 | PubMed |
| 11 | 2137658 | Influence of cyclic interferon gamma on lymphocytes and their subpopulations in patients with renal carcinoma. | Urology | 1990 | https://conductscience.org/library/papers/2137658 | PubMed |
| 12 | 6981813 | Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6981813 | PubMed |
| 13 | 2454879 | Cytokines in the control of beta-2 microglobulin release. II. In vivo studies with recombinant interferons and antigens. | Immunobiology | 1988 | https://conductscience.org/library/papers/2454879 | PubMed |
| 14 | 2947550 | Suppressor cell activities in autologous human tumor systems. Suppression of tumor immunity. | Arch Surg | 1986 | https://conductscience.org/library/papers/2947550 | PubMed |
| 15 | 2219564 | Immune status and immune therapy of renal cell carcinoma. | Urol Int | 1990 | https://conductscience.org/library/papers/2219564 | PubMed |
| 16 | 2411792 | Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes. | J Immunol | 1985 | https://conductscience.org/library/papers/2411792 | PubMed |
| 17 | 2949064 | Suppressor cell function in solid tumor cancer patients. | J Clin Oncol | 1987 | https://conductscience.org/library/papers/2949064 | PubMed |
| 18 | 2106352 | Clinical implications of increased plasma levels of CD8 in patients with hairy cell leukemia. | Blood | 1990 | https://conductscience.org/library/papers/2106352 | PubMed |
| 19 | 2970871 | Serum levels of CD8 antigen in childhood lymphoid malignancies: a possible indicator of increased suppressor cell activity in poor-risk patients. | Blood | 1988 | https://conductscience.org/library/papers/2970871 | PubMed |
| 20 | 1967552 | Differential expression of intercellular adhesion molecule 1 in primary and metastatic melanoma lesions. | Cancer Res | 1990 | https://conductscience.org/library/papers/1967552 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 36688998 | Low on-treatment levels of serum soluble CD8 (sCD8) predict better outcomes in advanced non-small cell lung cancer patients treated with atezolizumab. | Cancer Immunol Immunother | 2023 | https://conductscience.org/library/papers/36688998 |
Source PubMed
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| B2M | 567 | PubTator's text mining | https://conductscience.org/library/genes/567 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| SCD5 | 79966 | PubTator's text mining | https://conductscience.org/library/genes/79966 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8740979
GET https://conductscience.org/api/papers/v1/8740979/references?page=2